The Company today announces its intention to demerge certain operating and other assets and the business of the Group to Oxford Pharmascience Limited (“OPL”), following a Board strategic review of
The Company today announces its intention to demerge certain operating and other assets and the business of the Group to Oxford Pharmascience Limited (“OPL”), following a Board strategic review of